What are the side effects of Saizhi, and the adverse reactions of Saizhi

Analysis: Allergic reactions of various degrees (itching, redness, rash) are common. They are usually mild and tend to resolve as they continue. Severe reactions to diffuse dermatitis occur in individual cases.

Suggestions: It is best to go to a regular hospital for an examination and the condition has been diagnosed.

Allergic reactions of various degrees (itching, redness, rash) are common. They are usually mild and tend to resolve as they continue. Severe reactions to diffuse dermatitis occur in individual cases.

00- Changes in blood counts (agranulocytosis) are seen in cases. They often present with inflammation of the oral mucosa and pharynx, fever, and the formation of boils. As soon as any symptoms appear, especially in the first few weeks, patients should immediately stop taking this product and contact their doctor for blood counts.

These symptoms may also appear weeks or months after the onset of **. In most cases, they recover naturally.

00- Saizhi (methimazole tablets) rare drug fever.

00- Rare taste abnormalities: usually disappear after stopping taking methimazole tablets, but sometimes it takes several weeks to return to normal.

00- Occasionally, joint pain has been reported, often occurring gradually over the months following **. There are no signs of arthritis.

00- Jaundice in individual cases is usually caused by damage to the bile outflow tract or toxic inflammation of the liver, and these symptoms usually resolve after discontinuation of the drug.

00- Anecdotes of lymphadenitis, acute salivary gland swelling, decreased number of platelets or other blood components, vasculitis or neuritis, impaired general sensation, alopecia, methimazole tablets-mediated lupus erythematosus (an autoimmune disease whose symptoms disappear after discontinuation of methimazole tablets), and insulin autoimmune syndrome (with a significant decrease in blood glucose).

00- Saizhi (methimazole tablets) reduces the pathologically increased energy requirement due to hyperthyroidism. Therefore, it can cause weight gain without changing the diet. From a medical point of view, this is exactly what we want.

00- Under methimazole**, despite suppression of TSH (thyroid-stimulating hormone) levels, the enlarged thyroid gland continues to grow, which is due to the underlying disease, and the addition of thyroid hormone does not prevent its occurrence.

00- The onset or exacerbation of ocular disease occurs in patients with typical hyperthyroidism (endocrine eye disease) and is largely unrelated to thyroid disease. This complication itself does not require a change in the regimen and should not be considered an adverse effect of proper use of methimazole**.

00- A very low percentage of patients with methimazole tablets** develop long-term hypothyroidism without any surgery**. This is most likely not an adverse reaction of methimazole tablets, but is thought to be caused by the autoinflammatory reaction of thyroid tissue associated with the underlying disease.

00- If you experience any adverse reactions, contact your doctor immediately. He and she will take appropriate countermeasures. If you have agranulocytosis, medication fever or dysgeusia, he or she will ask you to stop methimazole** and prescribe other medications.

Where did you see the disease, my mother has had hyperthyroidism for more than 3 years and has not recovered, ask for a prescription or a hospital, thank you, and I hope you can get better soon.

The main ingredient of this product is methimazole, and its chemical name is: 1-methyl-1,3-dihydro-2H-imidazole-2-thiol Chemical structure: Molecular formula: C4H6N2S molecular weight:

Adverse effects were assessed based on the following incidence definitions: very common 1 10 common 1 100, 1 10 uncommon 1 1,000, 1 100 rare 1 10,000, 1 1,000 very rare 1 10,000 [u] hematologic and lymphatic system abnormalities [u] uncommon agranulocytosis occurs in approximately cases. Agranulocytosis can also occur weeks or months after the onset of agranulocytosis, and the drug must be discontinued if agranulocytosis is present.

Most cases recover spontaneously. Very rarely, thrombocytopenia, pancytopenia, generalized lymphadenopathy. [u] Endocrine abnormalities [u] Very rare insulin autoimmune syndrome (with a significant drop in blood glucose levels).

u] Neurological abnormalities [u] Rare and rare occurrence of taste disorders (dysgeusia, loss of taste); Recovery can be done after the drug is stopped. However, it may take several weeks to return to normal. Very rarely, neuritis, polyneuropathy.

u] Gastrointestinal abnormalities [u] Very rarely, acute salivary gland swelling. Hepatobiliary abnormalities are very rare, and cholestatic jaundice or toxic hepatitis has been reported in isolated cases. Symptoms usually return after stopping the drug.

Care must be taken to distinguish between insignificant clinical signs of cholestasis during ** and changes due to hyperthyroidism, such as elevated ggt(-glutamyl transpeptidase) and alkaline phosphatase or its bone-specific isoenzymes. [u]** and subcutaneous tissue abnormalities [u] are very common with allergic reactions of varying degrees (pruritus, rash, rubella). Most of these reactions are mild and often resolve while they continue.

Very rare severe allergic ** reactions, including generalized dermatitis, alopecia, drug-induced lupus erythematosus. [u] muscular and connective tissue abnormalities [u] common arthralgia may develop gradually, even after months. [u] general disease and administration site status [u] rare drug fever.

Drug overdose can lead to hypothyroidism, corresponding symptoms of metabolic decrease, and through the feedback effect, the adenohypophysis can be activated, followed by the growth of a goiter. This can be avoided by adding levothyroxine if necessary, when the dose is lowered as soon as the metabolic state of normal thyroid function is reached. Negative consequences of accidental ingestion of high doses of methimazole are unknown.

It is contraindicated in patients who: are hypersensitive to methimazole, other thiamide derivatives, or any of the excipients; moderate to severe blood count disturbances (neutropenia); pre-existing cholestasis not due to hyperthyroidism; Bone marrow damage after receiving methimazole or carbimazole**. During pregnancy, methimazole in combination with thyroid hormones is contraindicated**.

Cythalisis (methimazole tablets), the indication is · Drugs for hyperthyroidism**, especially in patients who do not have or have mild thyroid enlargement (goiter) and young patients. · It is used for pre-operative preparation for various types of hyperthyroidism. · Preparations for the use of radioactive iodine in patients with hyperthyroidism to prevent the occurrence of thyrotoxic crisis after **.

Intermittent period after radioactive iodine**. · In individual cases, long-term hyperthyroidism may be used due to the patient's general condition or personal reasons for not being able to use the usual ** measures, or because the patient refuses to accept the usual ** measures, due to the good tolerance of methimazole tablets (at the lowest possible dose). · It is used as a prophylactic agent in patients with a history of hyperthyroidism and in patients with functionally autonomous thyroid tumors who must be treated with iodine irradiation (eg, with iodine-containing contrast).